Clinical Domains

Home > Clinical Research > Clinical Domains

Clinical Domains

Early indication of cancers, metabolic, and chronic diseases

Medial EarlySign focuses on identifying those individuals with ‘rising risk’ in the population who are most likely to become tomorrow’s high-burden patients, in time for preventative action to be taken. This 5% of the population will eventually account for 50% of healthcare costs.


We are currently at various stages of developing dozens of AlgoMarkers™ – our predictive risk engines for a variety of healthcare outcomes. Our research ranges from the early prediction of cancers to personalized and outcome-based interpretation of lab results, flagging diabetics who are ‘at risk’ for nephropathy, data-driven risk tools for inpatients, and many other areas.



Contact us today to learn more.